These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. DNA methylation as a molecular biomarker in gastric cancer. Tahara T, Arisawa T. Epigenomics; 2015 Sep; 7(3):475-86. PubMed ID: 26077432 [Abstract] [Full Text] [Related]
31. Recent advances in the molecular diagnostics of gastric cancer. Kanda M, Kodera Y. World J Gastroenterol; 2015 Sep 14; 21(34):9838-52. PubMed ID: 26379391 [Abstract] [Full Text] [Related]
35. Epigenetic mechanisms in gastric cancer. Gigek CO, Chen ES, Calcagno DQ, Wisnieski F, Burbano RR, Smith MA. Epigenomics; 2012 Jun 14; 4(3):279-94. PubMed ID: 22690664 [Abstract] [Full Text] [Related]
36. Epigenetic inactivation of FAT4 contributes to gastric field cancerization. Yoshida S, Yamashita S, Niwa T, Mori A, Ito S, Ichinose M, Ushijima T. Gastric Cancer; 2017 Jan 14; 20(1):136-145. PubMed ID: 26792292 [Abstract] [Full Text] [Related]
38. Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer. Hu XT, Zhang FB, Fan YC, Shu XS, Wong AH, Zhou W, Shi QL, Tang HM, Fu L, Guan XY, Rha SY, Tao Q, He C. Oncogene; 2009 Jul 02; 28(26):2466-75. PubMed ID: 19448674 [Abstract] [Full Text] [Related]